View this page in: Français
PwC is pleased to present its fourth Canadian Life Sciences Industry Forecast, a survey conducted in collaboration with BIOTECanada. The online survey, conducted in August and September 2010, was completed by 100 respondents from corporate, academic, government and other organizations in the industry. The report is designed to understand the challenges and concerns of the Canadian life sciences industry, explore new trends and communicate reoccurring themes. The information gathered and contained within this report builds on findings from previous reports and provides an overview of current industry issues and trends. We trust that you will find the information valuable for augmenting the debate on these issues.
While years of scientific achievements are well known in the Canadian life sciences industry, the commercialization of the science is becoming more of a challenge as research moves east from a global perspective and raising capital from a Canadian perspective continues to be difficult.
The Canadian industry is at an inflection point. In these challenging economic times, Canadian companies continue to explore numerous options to raise desperately needed funds. They have shown great tenacity and perseverance in trying to build this vitally important sector of the Canadian economy. The challenge to sustain companies through the full cycle of commercialization remains a key priority for public policy leaders and the Canadian industry as we look toward long-term financial growth for Canada from the life sciences sector.
Download the report here.
About the PwC network
PwC firms provide industry-focused assurance, tax and advisory services to enhance value for their clients. More than 161,000 people in 154 countries in firms across the PwC network share their thinking, experience and solutions to develop fresh perspectives and practical advice. Click here for more information.